It hosts three production units dedicated to the manufacture and assembly of products and solutions for pharmaceutical manufacturing processes and applied solutions products for analysis in clinical and industrial environments and water purification systems.
It supplies the world market, exporting more than 85 percent of its production. With more than 1,700 employees of 32 different nationalities, and producing more than 10,000 products, the Molsheim hub is Merck’s third largest site globally. It is planned to be operational by the end of 2021. The new unit will produce Mobius ® single-use assemblies, a key offering that is part of Merck’s Mobius ® MyWay program. The investment in Molsheim will add more than 350 new jobs in total along with 1,700 square meters of ISO7 or ISO5 cleanrooms, using modular building design and existing infrastructure to allow future expansions without any disruptions. Today’s announcement of our expansion in Europe speaks of Merck’s global commitment during and beyond this pandemic,” said Belén Garijo, Vice Chair of the Executive Board and Deputy CEO of Merck. Our new European production unit will increase capacity of the urgently needed supply of single-use assemblies to vaccine and therapeutic manufacturers worldwide. Merck’s science and technology efforts have resulted in significant contributions since the outset of Covid-19. “The pandemic has confronted the world with inconceivable challenges. The project was announced today in Molsheim in the presence of EU Commissioner Thierry Breton and the French Minister Delegate for Industry, Agnès Pannier-Runacher. Further production sites are located in Danvers, Massachusetts, USA, and Wuxi, China. Molsheim will be the first site in Europe where Merck manufactures the product. With the € 25 million investment, the company is accelerating its European expansion plans for this key technology, which is used for the production of Covid-19 vaccines and other lifesaving therapies. Production capabilities anticipated to be operational by end of 2021ĭarmstadt, Germany, Ma– Merck, a leading science and technology company, will add a single-use assembly production unit at its Life Science Center in Molsheim, France.Response to unprecedented global demand of key technology.€ 25 million investment in Molsheim, France, will create 350 new jobs.
0 kommentar(er)
